1606 (CBDW) S-1 5 Nov 24 IPO registration Financial data

Cover

Cover	6 Months Ended
	Jun. 30, 2024
Cover [Abstract]
Entity Registrant Name	1606 Corp.
Entity Central Index Key	0001877461
Document Type	S-1
Amendment Flag	false
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Filer Category	Non-accelerated Filer
Entity Ex Transition Period	false
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	86-1497346
Entity Address Address Line 1	2425 E. Camelback Rd
Entity Address Address Line 2	Suite 150
Entity Address City Or Town	Phoenix
Entity Address State Or Province	AZ
Entity Address Postal Zip Code	85016
City Area Code	602
Local Phone Number	481-1544

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Current Assets
Cash	$ 75,004	$ 48,941	$ 105,065
Accounts receivable	2,762	3,600	0
Notes receivable	21,500	21,500	0
Inventory	72,769	72,853	113,174
Prepaids and other current assets	23,629	1,444	13,577
Total Current Assets	195,664	148,338	231,816
Total Assets	195,664	148,338	231,816
Current Liabilities
Accounts payable and accrued liabilities	494,768	295,041	25,188
Accrued interest	45,404	10,086	3,173
Note payable to related party	63,456	63,456	63,456
Convertible notes, net of discount	231,599	51,086	0
Derivative liability	62,520	193,026	0
Total Current Liabilities	897,747	612,695	91,817
Long Term Liabilities
Note payable to shareholder	1,220,550	950,550	735,050
Total Long Term Debt	1,220,550	950,550	735,050
Total Liabilities	2,118,297	1,563,245	826,867
Stockholders' Equity
Common Stock, par value $0.0001 per share, 5,000,000,000 shares authorized, 58,582,469 and 37,428,394 shares issued and outstanding, respectively	7,554	5,858	3,742
Additional paid-in capital	1,111,880	995,638	236,842
Accumulated deficit	(3,047,660)	(2,422,031)	(841,298)
Total Stockholders' Equity	(1,922,633)	(1,414,907)	(595,051)
Total Liabilities and Stockholders' Equity	195,664	148,338	231,816
Undesignated Preferred Stock [Member]
Stockholders' Equity
Preferred stock, value	0	0	0
Class A Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred stock, value	5,593	5,628	$ 5,663
Class B Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred stock, value	$ 0	$ 0

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	5,000,000,000	5,000,000,000	5,000,000,000
Common stock, shares issued	75,545,390	58,582,469	37,428,394
Common stock, shares outstanding	75,545,390	58,582,469	37,428,394
Preferred stock, shares issued	55,920,127
Undesignated Preferred Shares [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	39,999,900	40,000,000	40,000,000
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Class A Convertible Preferred Shares [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	60,000,000	60,000,000	60,000,000
Preferred stock, shares issued	55,920,127	56,282,599	56,635,000
Preferred stock, shares outstanding	55,920,127	56,282,599	56,635,000
Class B Convertible Preferred Shares [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	100	100
Preferred stock, shares issued	90	0
Preferred stock, shares outstanding	90	0

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
CONDENSED STATEMENTS OF OPERATIONS (Unaudited)
Revenue, net of discounts	$ 0	$ 304	$ 7,195	$ 1,474	$ 1,603	$ 13,944
Cost of goods sold	0	3,556	7,313	4,781	995	12,762
Gross profit	0	(3,252)	(118)	(3,307)	608	1,182
Operating Expenses
Selling, general and administrative	288,739	462,891	686,660	753,027	1,709,100	541,219
Write-off of investments	0	65,000	0	65,000	65,000	0
Total operating expenses	288,739	527,891	686,660	818,027	1,774,100	541,219
Operating loss	(288,739)	(531,143)	(686,778)	(821,334)	(1,773,492)	(540,037)
Other Income
Interest expense	(128,435)	(2,521)	(308,424)	(5,042)
Change in fair value of derivative liabilities	77,982	0	369,573	0	192,759	0
Total other expenses	(50,453)	(2,521)	61,149	(5,042)	192,759	0
Loss from operations before income taxes	(339,192)	(533,664)	(625,629)	(826,376)	(1,580,733)	(540,037)
Provision for income taxes	0	0	0	0	0	0
Net Loss	$ (339,192)	$ (533,664)	$ (625,629)	$ (826,376)	$ (1,580,733)	$ (540,037)
Net loss per share - basic and diluted	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.02)	$ (0.03)	$ (0.01)
Weighted average common shares - basic and diluted	50,843,473	44,326,744	52,962,639	43,541,222	47,322,946	37,144,459

CONDENSED STATEMENTS OF STOCKHO

CONDENSED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Class B Convertible Preferred Stock [Member]	Class A Convertible Preferred Stock [Member]
Balance, shares at Dec. 31, 2021		37,103,394				56,635,000
Balance, amount at Dec. 31, 2021	$ (217,514)	$ 3,710	$ 74,374	$ (301,261)		$ 5,663
Net loss	(540,037)	$ 0	$ 0	$ (540,037)
Balance, shares at Dec. 31, 2022		37,428,394	236,842	(841,298)		56,635,000
Balance, amount at Dec. 31, 2022	(595,051)	$ 3,742	$ 236,842	$ (841,298)	$ 0	$ 5,663
Net loss	(826,376)	0	0	(826,376)	0	0
Share conversions, amount	0	506	(486)	0	0	$ (20)
Preferred stock issued for services, shares						200,004
Preferred stock issued for services, amount	110,002	$ 0	109,982	0	0	$ 20
Common stock issued for cash, shares		725,000
Common stock issued for cash, amount	412,500	$ 73	412,427	0	0	$ 0
Share conversions, shares		5,060,125				(202,405)
Common stock issued for services, shares		2,945,087
Common stock issued for services, amount	83,001	$ 295	82,706	0	0	$ 0
Balance, shares at Jun. 30, 2023		46,158,606				56,632,599
Balance, amount at Jun. 30, 2023	(815,924)	$ 4,616	$ 841,471	$ (1,667,674)	0	$ 5,663
Balance, shares at Dec. 31, 2022		37,428,394	236,842	(841,298)		56,635,000
Balance, amount at Dec. 31, 2022	(595,051)	$ 3,742	$ 236,842	$ (841,298)	0	$ 5,663
Net loss	(1,580,733)	0	0	(1,580,733)		0
Share conversions, amount	0	1,381	1,326	0		$ (55)
Preferred stock issued for services, shares						200,004
Preferred stock issued for services, amount	110,002	$ 0	109,982	0		$ 20
Common stock issued for cash, shares		825,000
Common stock issued for cash, amount	$ 412,500	$ 83	412,417	0		$ 0
Share conversions, shares	552,405	13,810,125				(552,405)
Common stock issued for services, shares		6,518,950
Common stock issued for services, amount	$ 178,544	$ 652	177,892	0		$ 0
Settlement of derivative liability	59,831	$ 0	59,831	0		$ 0
Balance, shares at Dec. 31, 2023		58,582,469				56,282,599
Balance, amount at Dec. 31, 2023	(1,414,907)	$ 5,858	995,638	(2,422,031)	0	$ 5,628
Balance, shares at Mar. 31, 2023		43,213,519				56,432,595
Balance, amount at Mar. 31, 2023	(475,263)	$ 4,321	648,783	(1,134,010)	0	$ 5,643
Net loss	(533,664)	0	0	(533,664)	0	0
Share conversions, amount	143,003	$ 150	142,833	0	0	$ 20
Share conversions, shares		1,500,000				200,004
Common stock issued for cash, shares		1,445,087
Common stock issued for cash, amount	50,000	$ 145	49,855	0	0	$ 0
Balance, shares at Jun. 30, 2023		46,158,606				56,632,599
Balance, amount at Jun. 30, 2023	(815,924)	$ 4,616	841,471	(1,667,674)	0	$ 5,663
Balance, shares at Dec. 31, 2023		58,582,469				56,282,599
Balance, amount at Dec. 31, 2023	(1,414,907)	$ 5,858	995,638	(2,422,031)	0	$ 5,628
Net loss	(625,629)	0	0	(625,629)	0	0
Share conversions, amount	0	1,005	(966)	0	$ 0	$ (39)
Preferred stock issued for services, shares					90	40,000
Preferred stock issued for services, amount	60,000	$ 0	59,996	0	$ 0	$ 4
Common stock issued for cash, shares		3,929,408
Common stock issued for cash, amount	125,006	$ 393	124,613	0	0	$ 0
Share conversions, shares		10,061,800				(402,472)
Common stock issued for services, shares		900,000
Common stock issued for services, amount	43,400	$ 90	43,310	0	0	$ 0
Settlement of derivative liability	(151,440)	$ 0	(151,440)	0	0	0
Common stock issued note conversion, shares		2,071,713
Common stock issued note conversion, amount	40,937	$ 208	40,729	0	$ 0	$ 0
Balance, shares at Jun. 30, 2024		75,545,390			90	55,920,127
Balance, amount at Jun. 30, 2024	(1,922,633)	$ 7,554	1,111,880	(3,047,660)	$ 0	$ 5,593
Balance, shares at Mar. 31, 2024		65,881,177			90	56,207,827
Balance, amount at Mar. 31, 2024	(1,611,343)	$ 6,588	1,084,916	(2,708,468)	$ 0	$ 5,621
Net loss	(339,192)	0	0	(339,192)	0	0
Share conversions, amount	0	$ 718	(690)	0	0	$ (28)
Share conversions, shares		7,192,500				(287,700)
Common stock issued for services, shares		400,000
Common stock issued for services, amount	13,400	$ 40	13,360	0	0	$ 0
Settlement of derivative liability	(26,435)	$ 0	(26,435)	0	0	0
Common stock issued note conversion, shares		2,071,713
Common stock issued note conversion, amount	40,937	$ 208	40,729	0	$ 0	$ 0
Balance, shares at Jun. 30, 2024		75,545,390			90	55,920,127
Balance, amount at Jun. 30, 2024	$ (1,922,633)	$ 7,554	$ 1,111,880	$ (3,047,660)	$ 0	$ 5,593

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Cash Flows from Operating Activities
Net loss	$ (625,629)	$ (826,376)	$ (1,580,733)	$ (540,037)
Adjustments to reconcile net loss to net cash used in operating activities:
Preferred and common shares issued for services provided			288,546	0
Shares issued for services provided	103,400	193,003
Write-off of investments	0	65,000	65,000	0
Amortization of debt discount	217,628	0	119,324	0
Change in fair value of derivative liabilities	(369,573)	0
Financing cost			200,616	0
Change in fair value of derivative liabilities	(369,573)	0	(192,759)	0
Accounts receivable	838	(3,600)	(3,600)	0
Changes in operating assets and liabilities:
Inventory	84	(16,028)	40,321	(81,725)
Prepaids and other current assets	(22,185)	13,577	12,133	(13,577)
Accounts payable and accrued liabilities	199,727	13,207	269,852	25,188
Accrued Interest	48,676	5,042	29,195	0
Accrued expenses	0	132,083
Net cash used in operating activities	(447,034)	(424,092)	(747,104)	(610,151)
Cash Flows from Investing Activities
Investment in operating companies			(65,000)	0
Investment in note receivable			(21,500)	0
Increase in operating companies	0	(65,000)
Investment in note receivable	0	(21,500)
Net cash used in investing activities	0	(86,500)	(86,500)	0
Cash Flows from Financing Activities
Proceeds from stockholder			215,500	543,173
Proceeds from convertible notes	289,500	0	245,000	0
Increase in note payable to shareholder	270,000	20,000
Repayment of convertible notes	(211,409)	0	(95,520)	0
Proceeds from sale of common stock	125,006	412,500	412,500	162,500
Net cash provided by financing activities	473,097	432,500	777,480	705,673
Net increase (decrease) in cash	26,063	(78,092)	(56,124)	95,522
Cash, beginning of year	48,941	105,065	105,065	9,543
Cash, end of year	75,004	26,973	48,941	105,065
Supplemental disclosures of cash items
Interest paid	0	0	0	0
Income tax paid	0	0	0	0
Supplemental schedule of non-cash investing and financing activities
Discount on convertible notes payable from derivative liability	87,627	0	141,231	0
Settlement of derivative liability	151,440	0	$ 59,831	$ 0
Common stock issued note conversion	$ 40,937	$ 0

DESCRIPTION OF BUSINESS

DESCRIPTION OF BUSINESS	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
DESCRIPTION OF BUSINESS
DESCRIPTION OF BUSINESS	NOTE 1 - DESCRIPTION OF BUSINESS Corporate History 1606 Corp. (“1606” or the “Company”) was formed in February 2021 and was a division of Singlepoint Inc. (“Singlepoint”) until April 2021, when Singlepoint spun off 1606, whereby each holder of common stock and Class A preferred stock of Singlepoint received one share of unregistered and restricted common stock or Class A preferred stock of the Company for each such share owned of Singlepoint. Business The Company is an AI Chatbot company specializing in merchandizing bot specifically built for the CBD industry and AI Chatbots for public companies. Going Concern The accompanying condensed financial statements have been prepared assuming the Company will continue as a going concern. As of June 30, 2024, the Company has yet to achieve significant profitable operations and is dependent on its ability to raise capital from stockholders or other sources to sustain operations and to ultimately achieve viable operations. The condensed financial statements do not include any adjustments that might result from the outcome of these uncertainties. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue in existence is dependent on its ability to develop its business and to achieve profitable operations. Since the Company does not anticipate achieving profitable operations and/or adequate cash flows in the near term, management will continue to pursue additional equity financing through private placements of the Company’s common stock.	NOTE 1 - DESCRIPTION OF BUSINESS Corporate History 1606 Corp. (“1606” or the “Company”) was formed in February 2021 and was a division of Singlepoint Inc. (“Singlepoint”) until April 2021, when Singlepoint spun off 1606, whereby each holder of common stock and Class A preferred stock of Singlepoint received one share of unregistered and restricted common stock or Class A preferred stock of the Company for each such share owned of Singlepoint. Business The Company is an AI Chatbot company specializing in merchandizing bot specifically built for the CBD industry. Going Concern The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As of December 31, 2023, the Company has yet to achieve significant profitable operations and is dependent on its ability to raise capital from stockholders or other sources to sustain operations and to ultimately achieve viable operations. The financial statements do not include any adjustments that might result from the outcome of these uncertainties. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue in existence is dependent on its ability to develop its business and to achieve profitable operations. Since the Company does not anticipate achieving profitable operations and/or adequate cash flows in the near term, management will continue to pursue additional equity financing through private placements of the Company’s common stock.

BASIS OF PRESENTATION AND SUMMA

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying condensed financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly the Company’s financial position as of June 30, 2024 and December 31, 2023, and the results of the Company’s operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the financial statements and the notes included in our latest annual report on Form 10-K for the year ended December 31, 2023, and our other reports on file with the Securities and Exchange Commission (“SEC”). Management believes the assumptions underlying the Company’s standalone condensed financial statements are reasonable. Nevertheless, the accompanying condensed financial statements may not include all the actual expenses that would have been incurred had the Company operated as a standalone company during the periods presented, and may not reflect the Company’s results of operations, financial position and cash flows had the Company operated as a standalone company during the periods presented. Actual costs that would have been incurred if the Company had operated as a standalone company would depend on multiple factors, including organizational structure and strategic decisions made in various areas. Use of Estimates The preparation of the condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements, and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results may differ from those estimates. Cash Cash consists of highly liquid investments with an original maturity of three months or less. Accounts Receivable and Credit Policy Trade receivables due from customers are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. Management of the Company considers all receivables collectable. Uncollectable accounts are charged to expense when the account is determined to be uncollectable. The allowance is provided based upon a review of the individual accounts outstanding, prior history of uncollectable accounts receivable and existing economic conditions. At June 30, 2024 and December 31, 2023, the allowance for doubtful accounts balance is $0. Inventory Inventories are valued at the lower of cost or net realizable value, and consist primarily of hemp products. The Company’s inventory as of June 30, 2024 and 2023 consisted of finished hemp products. At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence, or shelf-life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand and the risk of technological or competitive obsolescence for products. To the extent that management determines there is excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value of this inventory to the lower of cost or net realizable value. No such adjustments were deemed necessary during the periods presented. Revenue Recognition The Company, which has adopted ASC 606 “Revenue from Contracts with Customers”, Cost of Goods Sold and Selling, General and Administrative Expenses Costs associated with the production and procurement of product are included in cost of goods sold, including shipping and handling costs such as inbound freight costs, purchasing, and receiving costs, inspection costs and other product procurement related charges. All other expenses are included in selling, general and administrative expenses, as the predominant expenses associated therewith are general and administrative in nature. Net Loss Per Common Share Basic loss per share data is computed using the weighted-average number of shares of common stock outstanding during the period. Diluted loss per share data is computed using the weighted-average number of common and dilutive common-equivalent shares outstanding during the period. Dilutive common-equivalent shares consist of shares that would be issued upon the exercise of stock options and other common stock equivalents, computed using the treasury stock method, and are excluded from the calculation of weighted average dilutive common shares, to the extent they are issued and outstanding, because their effect would be anti-dilutive. The number of potentially dilutive shares excluded from the calculation of diluted earnings per share were 2,265,400 related to the Company’s Class A preferred stock. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive. At June 30, 2024 and December 31, 2023, 75,545,390 and 58,582,469 shares of the Company’s common stock were outstanding, respectively. These share amounts are utilized for the calculation of basic and diluted earnings per share for years then ended. Selling and Marketing Selling and marketing costs are expensed as incurred and are reported under selling, general and administrative in the accompanying condensed statements of operations. Selling, general and administrative costs were $686,660 and $753,027 during the six months ended June 30, 2024 and 2023, respectively. Fair Value Measurement ASC Topic 820, “Fair Value Measurement”, requires that certain financial instruments be recognized at their fair values at our balance sheet dates. However, other financial instruments, such as debt obligations, are not required to be recognized at their fair values, but GAAP provides an option to elect fair value accounting for these instruments. GAAP requires the disclosure of the fair values of all financial instruments, regardless of whether they are recognized at their fair values or carrying amounts in our balance sheets. For financial instruments recognized at fair value, GAAP requires the disclosure of their fair values by type of instrument, along with other information, including changes in the fair values of certain financial instruments recognized in income or other comprehensive income. For financial instruments not recognized at fair value, the disclosure of their fair values is provided below under “Financial Instruments.” Nonfinancial assets, such as property, plant and equipment, and nonfinancial liabilities are recognized at their carrying amounts in the Company’s balance sheets. GAAP does not permit nonfinancial assets and liabilities to be remeasured at their fair values. However, GAAP requires the remeasurement of such assets and liabilities to their fair values upon the occurrence of certain events, such as the impairment of property, plant and equipment. In addition, if such an event occurs, GAAP requires the disclosure of the fair value of the asset or liability along with other information, including the gain or loss recognized in income in the period the remeasurement occurred. Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities; Level 2 - Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; or Level 3 - Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). The Company did not have any Level 1 or Level 2 assets and liabilities at June 30, 2024 or December 31, 2023. The Derivative liabilities are Level 3 fair value measurements. The following is a summary of activity of Level 3 liabilities for the period ended June 30, 2024: Balance - December 31, 2023 $ 193,026 Additions 87,627 Settlements 151,440 Change in fair value (369,573 ) Balance - June 30, 2024 $ 62,520 During 2023 and 2024, the Company issued note payable agreements which contain conversion provisions meeting the definition of a derivative liability which therefore require bifurcation. Further, pursuant to the Company’s contract ordering policy, equity linked instruments subsequently issued resulted in derivative liabilities. At June 30, 2024, the Company estimated the fair value of the conversion feature derivatives embedded in the notes payable and warrants based on assumptions used in the Cox-Ross-Rubinstein binomial pricing model using the following inputs: the price of the Company’s common stock of $0.0440; risk-free interest rates ranging from 5.20% to 5.45%; expected volatility of the Company’s common stock ranging from 112% to 117% based on the volatility of comparable publicly traded entities; and exercise prices ranging from $0.02 to $0.0215; and terms of four to nine months. At December 31, 2023, the Company estimated the fair value of the conversion feature derivatives embedded in the notes payable and warrants based on assumptions used in the Cox-Ross-Rubinstein binomial pricing model using the following inputs: the price of the Company’s common stock of $0.0285; risk-free interest rates ranging from 4.79% to 5.03%; expected volatility of the Company’s common stock ranging from 110% to 204% based on the volatility of comparable publicly traded entities; and exercise prices of $0.0182; and terms of eight to twelve months. Segment reporting The Company operates in a single business segment. As a result, the Company’s operations are a single reportable segment, which is consistent with the Company’s internal management reporting. Income Taxes In December 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. The Company will adopt ASU 2023-09 in its fourth quarter of 2026. ASU 2023-09 allows for adoption using either a prospective or retrospective transition method. Recent Accounting Pronouncements The Company has considered the potential impact of recent accounting pronouncements and has not identified any that are expected to have a material impact on the financial statements.	NOTE 2 - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These financial statements have been prepared using the accrual basis of accounting in accordance with Generally Accepted Accounting Principles of the United States (“U.S. GAAP”). Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results may differ from those estimates. Cash Cash consists of highly liquid investments with an original maturity of three months or less. Accounts Receivable and Credit Policy Trade receivables due from customers are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. Management of the Company considers all receivables collectable. Uncollectable accounts are charged to expense when the account is determined to be uncollectable. The allowance is provided based upon a review of the individual accounts outstanding, prior history of uncollectable accounts receivable and existing economic conditions. At December 31, 2023 and 2022, the allowance for doubtful accounts balance is $0. Inventory Inventories are valued at the lower of cost or net realizable value, and consist primarily of hemp products. The Company’s inventory as of December 31, 2023, and 2022 consisted of finished hemp products. At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence, or shelf-life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand and the risk of technological or competitive obsolescence for products. To the extent that management determines there is excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value of this inventory to the lower of cost or market. No such adjustments were deemed necessary during the periods presented. Investments Investments are recorded at cost and evaluated for impairment each balance sheet date. During the year ended December 31, 2023, the Company wrote-off investments of $15,000 and $50,000 initially made under the terms of a separate Letter of Intent and Member Interest Purchase Agreement, respectively in companies that operate in the hemp market. See Note 7 - Commitments and Contingencies. Revenue Recognition The Company, which has adopted ASC 606 “Revenue from Contracts with Customers”, Cost of Goods Sold and Selling, General and Administrative Expenses Costs associated with the production and procurement of product are included in cost of goods sold, including shipping and handling costs such as inbound freight costs, purchasing, and receiving costs, inspection costs and other product procurement related charges. All other expenses are included in selling, general and administrative expenses, as the predominant expenses associated therewith are general and administrative in nature. Income taxes Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement and tax bases of assets and liabilities at the applicable tax rates. Deferred tax assets are reduced by a valuation allowance when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates. Tax benefits are recognized from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by a tax authority and based upon the technical merits of the tax position. The tax benefit recognized in the financial statements for a particular tax position is based on the largest benefit that is more likely than not to be realized upon settlement. An unrecognized tax benefit, or a portion thereof, is presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. Net Loss Per Common Share Basic loss per share data is computed using the weighted-average number of shares of common stock outstanding during the period. Diluted loss per share data is computed using the weighted-average number of common and dilutive common-equivalent shares outstanding during the period. Dilutive common-equivalent shares consist of shares that would be issued upon the exercise of stock options and other common stock equivalents, computed using the treasury stock method, and are excluded from the calculation of weighted average dilutive common shares, to the extent they are issued and outstanding, because their effect would be anti-dilutive. The number of potentially dilutive shares excluded from the calculation of diluted earnings per share were 2,265,400 related to the Company’s Class A preferred stock. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive. At December 31, 2023 and 2022, 58,582,469 and 37,428,394 shares of the Company’s common stock were outstanding, respectively. These share amounts are utilized for the calculation of basic and diluted earnings per share for years then ended. Selling and Marketing Selling and marketing costs are expensed as incurred and are reported under selling, general and administrative in the accompanying statements of operations. Selling, general and administrative costs were $1,709,100 and $541,219 for the year ended December 31, 2023 and 2022, respectively. Fair Value Measurement ASC Topic 820, “Fair Value Measurement”, requires that certain financial instruments be recognized at their fair values at our balance sheet dates. However, other financial instruments, such as debt obligations, are not required to be recognized at their fair values, but GAAP provides an option to elect fair value accounting for these instruments. GAAP requires the disclosure of the fair values of all financial instruments, regardless of whether they are recognized at their fair values or carrying amounts in our balance sheets. For financial instruments recognized at fair value, GAAP requires the disclosure of their fair values by type of instrument, along with other information, including changes in the fair values of certain financial instruments recognized in income or other comprehensive income. For financial instruments not recognized at fair value, the disclosure of their fair values is provided below under “Financial Instruments.” Nonfinancial assets, such as property, plant and equipment, and nonfinancial liabilities are recognized at their carrying amounts in the Company’s balance sheets. GAAP does not permit nonfinancial assets and liabilities to be remeasured at their fair values. However, GAAP requires the remeasurement of such assets and liabilities to their fair values upon the occurrence of certain events, such as the impairment of property, plant and equipment. In addition, if such an event occurs, GAAP requires the disclosure of the fair value of the asset or liability along with other information, including the gain or loss recognized in income in the period the remeasurement occurred. Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities; Level 2 - Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; or Level 3 - Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). The Company did not have any Level 1 or Level 2 assets and liabilities at December 31, 2022 or 2023. The Derivative liabilities are Level 3 fair value measurements. The following is a summary of activity of Level 3 liabilities for the year ended December 31, 2023: Balance - December 31, 2022 $ - Additions 445,616 Settlements (59,831 ) Change in fair value (192,759 ) Balance - December 31, 2023 $ 193,026 Beginning on June 27, 2023, the Company issued note payable agreements which contain conversion provisions meeting the definition of a derivative liability which therefore require bifurcation. Further, pursuant to the Company’s contract ordering policy, equity linked instruments subsequent to June 27, 2023, resulted in derivative liabilities. At December 31, 2023, the Company estimated the fair value of the conversion feature derivatives embedded in the notes payable and warrants based on assumptions used in the Cox-Ross-Rubinstein binomial pricing model using the following inputs: the price of the Company’s common stock of $0.0285; risk-free interest rates ranging from 4.79% to 5.03%; expected volatility of the Company’s common stock ranging from 110% to 204% based on the volatility of comparable publicly traded entities; and exercise prices of $0.0182; and terms of eight to twelve months. Segment reporting The Company operates in a single business segment. As a result, the Company’s operations are a single reportable segment, which is consistent with the Company’s internal management reporting. Subsequent Events The Company has evaluated all subsequent events from December 31, 2023, through the date of filing of this report. and determined that there were no events or transactions required recognition or disclosure in the accompanying financial statements. (see Note 8). Recent Accounting Pronouncements The Company has considered the potential impact of recent accounting pronouncements and has not identified any that are expected to have a material impact on the financial statements.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 3 – RELATED PARTY TRANSACTIONS Related Party Transactions During the six months ended June 30, 2024, a total of 40,000 shares of Class A preferred stock was issued to the members of the Company’s Board of Directors for services provided. The value of all these shares was determined to be $60,000 based on an assumed conversion at a one-for-25 ratio of the Class A preferred stock for common shares and the closing market price of the common shares on the date of grant. During the six months ended June 30, 2024, a total of 90 shares of Series B preferred stock was issued to the Company’s Chief Executive Officer, Austen Lambrecht, and to the Company’s former Chief Executive Officer, Greg Lambrecht as Compensation for Services. On June 14, 2024, Gregory Lambrecht, gifted 60 shares of the Company’s Series B Preferred Stock to Austen Lambrecht. In June 2021, the Company entered into an Asset Purchase Agreement with Singlepoint to purchase certain assets in exchange for the issuance of a promissory note (the “Note”) for $63,456. The Note bears interest at 5%, has a three-year term, and is due in monthly installments of $1,902 beginning August 1, 2021. The Company has not made any payments on the Note and is currently in default. Accrued interest on the Note totaled $7,928 and $6,346 at June 30, 2024 and December 31, 2023, respectively.	NOTE 3 – RELATED PARTY TRANSACTIONS Related Party Transactions During the year ended December 31, 2023, a total of 200,001 shares of Class A preferred stock were issued to the Company’s Vice President, Austen Lambrecht, the son of Greg Lambrecht, the Company’s Chief Executive Officer (“CEO”). In addition, one share of Class A preferred stock was issued to Greg Lambrecht and each of the two other members of the Company’s Board of Directors for services provided. See Note 5 - Capital Stock During the year ended December 31, 2023, 552,405 shares of Class A preferred stock were converted into 13,810,125 common shares. During the years ended December 31, 2023 and 2022, the Company borrowed $215,500 and $540,000, respectively in a series of cash payments from the Company’s CEO in exchange for the issuance of a promissory note. The promissory note is not secured by Company assets, does not bear interest and is due in full on March 15, 2025. The promissory note totals $950,550 at December 31, 2023. In June 2021, the Company entered into an Asset Purchase Agreement with Singlepoint to purchase certain assets in exchange for the issuance of a promissory note (the “Note”) for $63,456. The Note bears interest at 5%, has a three-year term, and is due in monthly installments of $1,902 beginning August 1, 2021. The Company has not made any payments on the Note and is currently in default. Accrued interest on the Note totaled $6,346 and $3,173 at December 31, 2023 and 2022, respectively.

DEBT

DEBT	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
DEBT
Debt	NOTE 4 – DEBT Promissory Notes Payable - Related Party During the six months ended June 30, 2024 and 2023, the Company borrowed $270,000 and $2,521, respectively, in a series of cash payments from the Company’s Former CEO in exchange for the issuance of a promissory note. The promissory note is not secured by Company assets, does not bear interest and is due in full on March 15, 2025. The promissory note totals $1,220,550 at June 30, 2024. In June 2021, the Company entered into an Asset Purchase Agreement with Singlepoint to purchase certain assets in exchange for the issuance of a promissory note (the “Note”) for $63,456. The Note bears interest at 5%, has a three-year term, and is due in monthly installments of $1,902 beginning August 1, 2021. The Company has not made any payments on the Note and is currently in default. Accrued interest on the Note totaled $7,928 and $6,346 at June 30, 2024 and December 31, 2023, respectively. Convertible Notes Payable From January 19, 2024, to June 21, 2024, the Company issued five notes payable which, upon an event of default, contain a conversion feature meeting the definition of a derivative liability. Pursuant to the Company’s contract ordering policy, the conversion features were valued at $87,627 upon issuance and recorded as a derivative liability, resulting in additional debt discounts totaling $87,627. During the six months ended June 30, 2024, the Company made payments on convertible notes payable and a note payable, resulting in a settlement of derivative liabilities totaling $151,440. During the six months ended June 30, 2024, the Company amortized $47,204 of debt discount resulting in an unamortized debt discount of $58,385 and carrying value of $231,599 as of June 30, 2024. Accrued interest as of June 30, 2024 was $37,476. Scheduled maturities of debt remaining as of June 30, 2024 for each respective fiscal year end are as follows: 2024 $ 295,055 2025 1,220,550 Total $ 1,515,605	NOTE 4 – DEBT Promissory Notes Payable - Related Party During the years ended December 31, 2023 and 2022, the Company borrowed $215,500 and $540,000, respectively in a series of cash payments from the Company’s CEO in exchange for the issuance of a promissory note. The promissory note is not secured by Company assets, does not bear interest and is due in full on March 15, 2025. The promissory note totals $950,550 at December 31, 2023. In June 2021, the Company entered into an Asset Purchase Agreement with Singlepoint to purchase certain assets in exchange for the issuance of a promissory note (the “Note”) for $63,456. The Note bears interest at 5%, has a three-year term, and is due in monthly installments of $1,902 beginning August 1, 2021. The Company has not made any payments on the Note and is currently in default. Accrued interest on the Note totaled $6,346 and $3,173 at December 31, 2023 and December 31, 2022, respectively. Convertible Notes Payable During the year ended December 31, 2023, the Company entered into a series of convertible promissory note agreements in the amount of $204,488. The notes have a 1-year term, bear interest of 8-9%, and have a conversion price equal to 65% of the lowest trading price for the common stock during the ten-day period prior to the conversion date. The Company recorded $9,476 to the original debt discount. During the year ended December 31, 2023, the Company amortized $3,653 of debt discount resulting in an unamortized debt discount of $20,323 and carrying value of $178,653 as of December 31, 2023. Accrued interest as of December 31, 2023 was $2,714. From June 27, 2023 to December 19, 2023, the Company issued three convertible notes payable which contain a conversion feature meeting the definition of a derivative liability. Pursuant to the Company’s contract ordering policy, the conversion features were valued at $445,616 upon issuance and recorded as a derivative liability, resulting in additional debt discounts totaling $249,000. On December 20, 2023, the Company repaid a convertible note payable prior to maturity, resulting in a settlement of derivative liabilities totaling $59,831. Scheduled maturities of debt remaining as of December 31, 2023 for each respective fiscal year end are as follows: 2024 $ 114,542 2025 950,550 Total $ 1,065,092

CAPITAL STOCK

CAPITAL STOCK	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
CAPITAL STOCK
CAPITAL STOCK	NOTE 5 - CAPITAL STOCK Capital Stock As of June 30, 2024, the Company’s authorized capital stock consists of 5,000,000,000 shares of common stock at $0.0001 par value per share and 100,000,000 shares of preferred stock at $0.0001 par value per share. The Company has designated 60,000,000 shares of preferred stock as Class A convertible preferred stock (the “Class A Preferred Stock”), and 100 shares of preferred stock as Series B super voting preferred stock (the “Series B Preferred Stock”). The remaining 39,999,900 of preferred stock remains undesignated. As of June 30, 2024, there were 55,920,127 shares of the Class A Preferred Stock, 90 shares of the Series B Preferred Stock and 75,545,390 shares of common stock issued and outstanding. Common Stock The holders of common stock are entitled to one vote for each share held. The affirmative vote of a majority of votes cast at a meeting which commences with a lawful quorum is sufficient for approval of most matters upon which shareholders may or must vote, including the questions presented for approval or ratification at the Company’s Annual Shareholders’ Meeting. An amendment of the Company’s Articles of Incorporation, however, requires the affirmative vote of a majority of the Company’s total voting power for approval. Common shares do not carry cumulative voting rights, and holders of more than 50% of the common stock have the power to elect all directors and, as a practical matter, to control the Company. Holders of common stock are not entitled to preemptive rights, and the common stock may only be redeemed at the Company’s election. During the six months ended June 30, 2024, the Company issued 16,962,921 shares of its common stock, including: - 10,061,800 shares of its common stock upon conversion of 402,472 shares of Class A preferred stock; - 3,929,408 shares of its common stock for a total purchase price of $125,006; - 900,000 shares of its common stock for various services provided, valued at $43,400 based on the closing market price of the common shares on the grant date; - 2,071,713 shares of its common stock upon conversion of convertible notes in the amount of $40,937. Class A Preferred Stock The Class A preferred stock has certain material rights and preferences (as is more fully set forth in the Certificate of Designation of the Class A Preferred Stock). During the six months ended June 30, 2024, a total of 40,000 shares of Class A preferred stock was issued to the members of the Company’s Board of Directors for services provided. The value of all these shares was determined to be $60,000 based on an assumed conversion at a one-for-25 ratio of the Class A preferred stock for common shares and the closing market price of the common shares on the date of grant. During the six months ended June 30, 2024, 402,472 shares of Class A preferred stock were converted into 10,061,800 common shares. As of June 30, 2024, the Company had 55,920,127 shares of Class A preferred stock outstanding, of which 31,102,596 shares are held by the Company’s CEO. The former officers and directors of Singlepoint hold the remaining shares of the Class A preferred stock. Ranking The Class A preferred stock ranks, as to dividends and upon liquidation, senior and prior to the common stock of the Company. Liquidation In the event of liquidation, dissolution or winding up of the Company, the holders of the Class A preferred stock are entitled, out of the assets of the Company legally available for distribution, to receive, before any payment to the holders of shares of common stock or any other class or series of stock ranking junior, and amount per share equal to $1.00. Voting Each share of Class A preferred stock entitles the holder thereof to 50 votes on any matters requiring a shareholder vote of the Company. Conversion Each share of our Class A preferred stock is convertible into common stock on a one-for-25 basis at the option of the holder. Series B Super Voting Preferred Stock The Series B preferred stock has certain material rights and preferences (as is more fully set forth in the Certificate of Designation of the Series B Preferred Stock). During the six months ended June 30, 2024, a total of 90 shares of Class A preferred stock was issued to the two members of the Company’s Board of Directors. As of June 30, 2024, the Company had 90 shares of Series B preferred stock outstanding. Dividends There will be no dividends due or payable on the Series B Preferred Stock. Liquidation Rights Upon the occurrence of a “Liquidation Event,” the holders of Series B Preferred Stock are entitled to receive net assets on a pro-rata basis. Each holder of Series B Preferred Stock is entitled to receive ratably any dividends declared by the Board, if any, out of funds legally available for the payment of dividends. “Liquidation Event” means (i) the liquidation, dissolution or winding-up, whether voluntary or involuntary, of the Company, (ii) the purchase or redemption by the Company of shares of any class of stock or the merger or consolidation of the Company with or into any other corporation or corporations, or (iii) the sale, license or lease of all or substantially all, or any material part of, the Company’s assets. Conversion Rights The shares of Series B Preferred Stock are not convertible into shares of the Company’s Common Stock. Voting Rights If at least one share of Series B Preferred Stock is issued and outstanding, then the total aggregate issued shares of Series B Preferred Stock at any given time, regardless of their number, shall have voting rights equal to 10 times the sum of: i) the total number of shares of Common Stock which are issued and outstanding at the time of voting, plus ii) the total number of votes of all other series of Preferred Stocks which are issued and outstanding at the time of voting. Each individual share of Series B Preferred Stock shall have the voting rights equal to: [ten times the sum of: {all shares of Common Stock issued and outstanding at the time of voting + the total number of votes of all other series of Preferred Stocks which are issued and outstanding at the time of voting}] Divided by: [the number of shares of Series B Preferred Stock issued and outstanding at the time of voting] With respect to all matters upon which stockholders are entitled to vote or to which stockholders are entitled to give consent, the holders of the outstanding shares of Series B Preferred Stock shall vote together with the holders of Common Stock without regard to class, except as to those matters on which separate class voting is required by applicable law or the Articles of Incorporation or Bylaws.	NOTE 5 - CAPITAL STOCK Capital Stock As of December 31, 2023, the Company’s authorized capital stock consists of 5,000,000,000 shares of common stock at $0.0001 par value per share and 100,000,000 shares of preferred stock at $0.0001 par value per share. The Company has designated 60,000,000 shares of preferred stock as Class A convertible preferred stock (the “Class A Preferred Stock”). The remaining 40,000,000 of preferred stock remains undesignated. As of December 31, 2023, there were 56,282,599 shares of Class A preferred stock and 58,582,469 shares of common stock issued and outstanding. Common Stock The holders of common stock are entitled to one vote for each share held. The affirmative vote of a majority of votes cast at a meeting which commences with a lawful quorum is sufficient for approval of most matters upon which shareholders may or must vote, including the questions presented for approval or ratification at the Company’s Annual Shareholders’ Meeting. An amendment of the Company’s Articles of Incorporation, however, requires the affirmative vote of a majority of the Company’s total voting power for approval. Common shares do not carry cumulative voting rights, and holders of more than 50% of the common stock have the power to elect all directors and, as a practical matter, to control the Company. Holders of common stock are not entitled to preemptive rights, and the common stock may only be redeemed at the Company’s election. During the year ended December 31, 2023, the Company issued 6,518,950 shares of its common stock in payment for various services provided. The shares had a fair value of $178,544 based on the closing market price of the common shares on the date of grant. During the year ended December 31, 2023, the Company issued 13,810,125 common shares upon conversion of 552,405 shares of Class A preferred stock and sold 825,000 common shares at $0.50 per share for a total purchase price of $412,500. During the year ended December 31, 2022, the Company sold 325,000 common shares at $0.50 per share for a total purchase price of $162,500. Preferred Stock As of December 31, 2023, the Company had 56,282,599 shares of Class A preferred stock outstanding, of which 31,092,596 shares are held by the Company’s CEO. The former officers and directors of Singlepoint hold the remaining shares of the Class A preferred stock. The Class A preferred stock has certain material rights and preferences (as is more fully set forth in the Certificate of Designation of the Class A Preferred Stock). During the year ended December 31, 2023, a total of 200,001 shares of Class A preferred stock was issued to the Company’s Vice President, Austen Lambrecht and one share of Class A preferred stock was issued to Greg Lambrecht and each of the two other members of the Company’s Board of Directors for services provided. The value of all these shares was determined to be $110,002 based on an assumed conversion at a one-for-25 ratio of the Class A preferred stock for common shares and the closing market price of the common shares on the date of grant. During the year ended December 31, 2023, 552,405 shares of Class A preferred stock were converted into 13,810,125 common shares. No shares of the Company’s Class A preferred stock were issued during the quarter and year ended December 31, 2022. Ranking The Class A preferred stock ranks, as to dividends and upon liquidation, senior and prior to the common stock of the Company. Liquidation In the event of liquidation, dissolution or winding up of the Company, the holders of the Class A preferred stock are entitled, out of the assets of the Company legally available for distribution, to receive, before any payment to the holders of shares of common stock or any other class or series of stock ranking junior, and amount per share equal to $1.00. Voting Each share of Class A preferred stock entitles the holder thereof to 50 votes on any matters requiring a shareholder vote of the Company. Conversion Each share of our Class A preferred stock is convertible into common stock on a one-for-25 basis at the option of the holder.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2023
INCOME TAXES
INCOME TAXES	NOTE 6 – INCOME TAXES The Company accounts for its income taxes in accordance with ASC 740 “Income Taxes” Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. The Company has a net operating loss carryforward, however, due to the uncertainty of realization, the Company has provided a full valuation allowance for deferred tax assets resulting from this net operating loss carryforward. The components of income tax expense for the years ended December 31, 2023 and 2022, consist of the following: 2023 2022 Federal tax statutory rate 21.0 % 21.0 % Permanent differences - % - % Valuation allowance (21.0 )% (21.0 )% Effective rate - % - % Significant components of the Company’s estimated deferred tax assets and liabilities as of December 31, 2023 and 2022 are as follows: 2023 2022 Deferred tax assets: Net operating loss carryforwards $ 537,032 $ 265,673 Total deferred tax asset 537,032 265,673 Valuation allowance (537,032 ) (265,673 ) Net deferred tax assets $ - $ -

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 6 - COMMITMENTS AND CONTINGENCIES Legal Proceedings and Other Claims From time to time, we are a party to claims and actions for matters arising out of our business operations. We regularly evaluate the status of the legal proceedings and other claims in which we are involved to assess whether a loss is probable or there is a reasonable possibility that a loss, or an additional loss, may have been incurred and determine if accruals are appropriate. If accruals are not appropriate, we further evaluate each legal proceeding to assess whether an estimate of possible loss or range of possible loss can be made for disclosure. Although the outcome of claims and litigation is inherently unpredictable, we believe that we have adequate provisions for any probable and estimable losses. It is possible, nevertheless, that our financial position, results of operations or liquidity could be materially and adversely affected in any particular period by the resolution of a claim or legal proceeding. Legal expenses related to defense, negotiations, settlements, rulings, and advice of outside legal counsel are expensed as incurred. Employment Agreements Effective February 28, 2024, the Company entered into the Employment Agreement with Gregory Lambrecht, the Company’s Chief Executive Officer (the “ CEO Agreement Effective May 28, 2024, Gregory Lambrecht resigned as the Chief Executive Officer, Chief Financial Officer, and Chairman of the Board of the Company. Effective February 28, 2024, the Company entered into the Employment Agreement with Austen Lambrecht, the Company’s Vice President (the “ VP Agreement Effective May 28, 2024, the Board of Directors of the Company (with Austen Lambrecht abstaining) appointed Austen Lambrecht as Chief Executive Officer (Principal Executive Officer), Chief Financial Officer (Principal Financial and Accounting Officer), and Chairman of the Board of the Company. In February 2023, the Company entered into an employment agreement with Austen Lambrecht. The agreement provides that Austen Lambrecht would serve as Vice President for a term of three years at an annual salary of Eighty-Five Thousand Dollars ($85,000), with an incentive bonus and stock options as determined by the Board of Directors. The agreement automatically renews for additional six-month periods unless either party has provided written termination of this Agreement at least 90 days prior to the expiration of such term. The agreement also provides for compensation under certain severance and change of control circumstance of twelve months of salary and other bonus dollars that may be due. In May 2021, the Company entered into an employment agreement with Greg Lambrecht. The agreement provides that Mr. Lambrecht would serve as Chief Executive Officer Company for a term of three years at an annual salary of Two Hundred Fifty Thousand Dollars ($250,000), and an incentive bonus as determined by the Board of Directors. The agreement automatically renews for additional six-month periods unless either party has provided written termination of this Agreement at least 90 days prior to the expiration of such term.	NOTE 7 - COMMITMENTS AND CONTINGENCIES Letter of Intent On February 22, 2023, the Company entered into a Letter of Intent for the acquisition of a Fifty-One Percent (51%) ownership interest in a natural therapeutic products company for total purchase consideration of $7,140,000 consisting of cash payments of $150,000 and $6,990,000 in Company common stock. During the year ended December 31, 2023, the Company wrote off the initial $15,000 investment as it was determined the acquisition would not move forward and recovery of the amount was uncertain. Membership Interest Purchase Agreement On February 28, 2023, the Company entered into a Membership Interest Purchase Agreement for the acquisition of Fifty-One Percent (51%) of the Membership Units of a hemp distribution company for total purchase consideration consisting of 230,559 shares of the Company’s common stock and a cash payment of $50,000. During the year ended December 31, 2023, the Company wrote off the initial $50,000 investment as it was determined the acquisition would not move forward and recovery of the amount was uncertain. Legal Proceedings and Other Claims From time to time, we are a party to claims and actions for matters arising out of our business operations. We regularly evaluate the status of the legal proceedings and other claims in which we are involved to assess whether a loss is probable or there is a reasonable possibility that a loss, or an additional loss, may have been incurred and determine if accruals are appropriate. If accruals are not appropriate, we further evaluate each legal proceeding to assess whether an estimate of possible loss or range of possible loss can be made for disclosure. Although the outcome of claims and litigation is inherently unpredictable, we believe that we have adequate provisions for any probable and estimable losses. It is possible, nevertheless, that our financial position, results of operations or liquidity could be materially and adversely affected in any particular period by the resolution of a claim or legal proceeding. Legal expenses related to defense, negotiations, settlements, rulings, and advice of outside legal counsel are expensed as incurred. Employment Agreements In February 2023, the Company entered into an employment agreement with Austen Lambrecht. The agreement provides that Austen Lambrecht would serve as Vice President for a term of three years at an annual salary of Eighty-Five Thousand Dollars ($85,000), with an incentive bonus and stock options as determined by the Board of Directors. The agreement automatically renews for additional six-month periods unless either party has provided written termination of this Agreement at least 90 days prior to the expiration of such term. The agreement also provides for compensation under certain severance and change of control circumstance of twelve months of salary and other bonus dollars that may be due. In May 2021, the Company entered into an employment agreement with Greg Lambrecht. The agreement provides that Mr. Lambrecht would serve as Chief Executive Officer Company for a term of three years at an annual salary of Two Hundred Fifty Thousand Dollars ($250,000), and an incentive bonus as determined by the Board of Directors. The agreement automatically renews for additional six-month periods unless either party has provided written termination of this Agreement at least 90 days prior to the expiration of such term. All of the salary was accrued and unpaid.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 7 – SUBSEQUENT EVENTS Management of the Company has performed a review of all events and transactions occurring after June 30, 2024 for items that would require adjustment to or disclosure in the accompanying condensed financial statements. Noting a $70,150 convertible promissory note that was entered into on July 22, 2024 and the Company issued 5,337,924 shares of common stock to GHS investments, LLC for aggregate considerations of $131,405.68.	NOTE 8 – SUBSEQUENT EVENTS None

BASIS OF PRESENTATION AND SUM_2

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	The accompanying condensed financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly the Company’s financial position as of June 30, 2024 and December 31, 2023, and the results of the Company’s operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the financial statements and the notes included in our latest annual report on Form 10-K for the year ended December 31, 2023, and our other reports on file with the Securities and Exchange Commission (“SEC”). Management believes the assumptions underlying the Company’s standalone condensed financial statements are reasonable. Nevertheless, the accompanying condensed financial statements may not include all the actual expenses that would have been incurred had the Company operated as a standalone company during the periods presented, and may not reflect the Company’s results of operations, financial position and cash flows had the Company operated as a standalone company during the periods presented. Actual costs that would have been incurred if the Company had operated as a standalone company would depend on multiple factors, including organizational structure and strategic decisions made in various areas.	The financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These financial statements have been prepared using the accrual basis of accounting in accordance with Generally Accepted Accounting Principles of the United States (“U.S. GAAP”).
Use of Estimates	The preparation of the condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements, and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results may differ from those estimates.	The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results may differ from those estimates.
Cash	Cash consists of highly liquid investments with an original maturity of three months or less.	Cash consists of highly liquid investments with an original maturity of three months or less.
Accounts Receivable and Credit Policy	Trade receivables due from customers are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. Management of the Company considers all receivables collectable. Uncollectable accounts are charged to expense when the account is determined to be uncollectable. The allowance is provided based upon a review of the individual accounts outstanding, prior history of uncollectable accounts receivable and existing economic conditions. At June 30, 2024 and December 31, 2023, the allowance for doubtful accounts balance is $0.	Trade receivables due from customers are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. Management of the Company considers all receivables collectable. Uncollectable accounts are charged to expense when the account is determined to be uncollectable. The allowance is provided based upon a review of the individual accounts outstanding, prior history of uncollectable accounts receivable and existing economic conditions. At December 31, 2023 and 2022, the allowance for doubtful accounts balance is $0.
Inventory	Inventories are valued at the lower of cost or net realizable value, and consist primarily of hemp products. The Company’s inventory as of June 30, 2024 and 2023 consisted of finished hemp products. At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence, or shelf-life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand and the risk of technological or competitive obsolescence for products. To the extent that management determines there is excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value of this inventory to the lower of cost or net realizable value. No such adjustments were deemed necessary during the periods presented.	Inventories are valued at the lower of cost or net realizable value, and consist primarily of hemp products. The Company’s inventory as of December 31, 2023, and 2022 consisted of finished hemp products. At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence, or shelf-life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand and the risk of technological or competitive obsolescence for products. To the extent that management determines there is excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value of this inventory to the lower of cost or market. No such adjustments were deemed necessary during the periods presented.
Investments		Investments are recorded at cost and evaluated for impairment each balance sheet date. During the year ended December 31, 2023, the Company wrote-off investments of $15,000 and $50,000 initially made under the terms of a separate Letter of Intent and Member Interest Purchase Agreement, respectively in companies that operate in the hemp market. See Note 7 - Commitments and Contingencies.
Revenue Recognition	The Company, which has adopted ASC 606 “Revenue from Contracts with Customers”,	The Company, which has adopted ASC 606 “Revenue from Contracts with Customers”,
Cost of Goods Sold and Selling, General and Administrative Expenses	Costs associated with the production and procurement of product are included in cost of goods sold, including shipping and handling costs such as inbound freight costs, purchasing, and receiving costs, inspection costs and other product procurement related charges. All other expenses are included in selling, general and administrative expenses, as the predominant expenses associated therewith are general and administrative in nature.	Costs associated with the production and procurement of product are included in cost of goods sold, including shipping and handling costs such as inbound freight costs, purchasing, and receiving costs, inspection costs and other product procurement related charges. All other expenses are included in selling, general and administrative expenses, as the predominant expenses associated therewith are general and administrative in nature.
Income Taxes	In December 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. The Company will adopt ASU 2023-09 in its fourth quarter of 2026. ASU 2023-09 allows for adoption using either a prospective or retrospective transition method.	Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement and tax bases of assets and liabilities at the applicable tax rates. Deferred tax assets are reduced by a valuation allowance when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates. Tax benefits are recognized from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by a tax authority and based upon the technical merits of the tax position. The tax benefit recognized in the financial statements for a particular tax position is based on the largest benefit that is more likely than not to be realized upon settlement. An unrecognized tax benefit, or a portion thereof, is presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed.
Net Loss Per Common Share	Basic loss per share data is computed using the weighted-average number of shares of common stock outstanding during the period. Diluted loss per share data is computed using the weighted-average number of common and dilutive common-equivalent shares outstanding during the period. Dilutive common-equivalent shares consist of shares that would be issued upon the exercise of stock options and other common stock equivalents, computed using the treasury stock method, and are excluded from the calculation of weighted average dilutive common shares, to the extent they are issued and outstanding, because their effect would be anti-dilutive. The number of potentially dilutive shares excluded from the calculation of diluted earnings per share were 2,265,400 related to the Company’s Class A preferred stock. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive. At June 30, 2024 and December 31, 2023, 75,545,390 and 58,582,469 shares of the Company’s common stock were outstanding, respectively. These share amounts are utilized for the calculation of basic and diluted earnings per share for years then ended.	Basic loss per share data is computed using the weighted-average number of shares of common stock outstanding during the period. Diluted loss per share data is computed using the weighted-average number of common and dilutive common-equivalent shares outstanding during the period. Dilutive common-equivalent shares consist of shares that would be issued upon the exercise of stock options and other common stock equivalents, computed using the treasury stock method, and are excluded from the calculation of weighted average dilutive common shares, to the extent they are issued and outstanding, because their effect would be anti-dilutive. The number of potentially dilutive shares excluded from the calculation of diluted earnings per share were 2,265,400 related to the Company’s Class A preferred stock. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive. At December 31, 2023 and 2022, 58,582,469 and 37,428,394 shares of the Company’s common stock were outstanding, respectively. These share amounts are utilized for the calculation of basic and diluted earnings per share for years then ended.
Selling and Marketing		Selling and marketing costs are expensed as incurred and are reported under selling, general and administrative in the accompanying statements of operations. Selling, general and administrative costs were $1,709,100 and $541,219 for the year ended December 31, 2023 and 2022, respectively.
Fair Value measurements	ASC Topic 820, “Fair Value Measurement”, requires that certain financial instruments be recognized at their fair values at our balance sheet dates. However, other financial instruments, such as debt obligations, are not required to be recognized at their fair values, but GAAP provides an option to elect fair value accounting for these instruments. GAAP requires the disclosure of the fair values of all financial instruments, regardless of whether they are recognized at their fair values or carrying amounts in our balance sheets. For financial instruments recognized at fair value, GAAP requires the disclosure of their fair values by type of instrument, along with other information, including changes in the fair values of certain financial instruments recognized in income or other comprehensive income. For financial instruments not recognized at fair value, the disclosure of their fair values is provided below under “Financial Instruments.” Nonfinancial assets, such as property, plant and equipment, and nonfinancial liabilities are recognized at their carrying amounts in the Company’s balance sheets. GAAP does not permit nonfinancial assets and liabilities to be remeasured at their fair values. However, GAAP requires the remeasurement of such assets and liabilities to their fair values upon the occurrence of certain events, such as the impairment of property, plant and equipment. In addition, if such an event occurs, GAAP requires the disclosure of the fair value of the asset or liability along with other information, including the gain or loss recognized in income in the period the remeasurement occurred. Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities; Level 2 - Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; or Level 3 - Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). The Company did not have any Level 1 or Level 2 assets and liabilities at June 30, 2024 or December 31, 2023. The Derivative liabilities are Level 3 fair value measurements. The following is a summary of activity of Level 3 liabilities for the period ended June 30, 2024: Balance - December 31, 2023 $ 193,026 Additions 87,627 Settlements 151,440 Change in fair value (369,573 ) Balance - June 30, 2024 $ 62,520 During 2023 and 2024, the Company issued note payable agreements which contain conversion provisions meeting the definition of a derivative liability which therefore require bifurcation. Further, pursuant to the Company’s contract ordering policy, equity linked instruments subsequently issued resulted in derivative liabilities. At June 30, 2024, the Company estimated the fair value of the conversion feature derivatives embedded in the notes payable and warrants based on assumptions used in the Cox-Ross-Rubinstein binomial pricing model using the following inputs: the price of the Company’s common stock of $0.0440; risk-free interest rates ranging from 5.20% to 5.45%; expected volatility of the Company’s common stock ranging from 112% to 117% based on the volatility of comparable publicly traded entities; and exercise prices ranging from $0.02 to $0.0215; and terms of four to nine months. At December 31, 2023, the Company estimated the fair value of the conversion feature derivatives embedded in the notes payable and warrants based on assumptions used in the Cox-Ross-Rubinstein binomial pricing model using the following inputs: the price of the Company’s common stock of $0.0285; risk-free interest rates ranging from 4.79% to 5.03%; expected volatility of the Company’s common stock ranging from 110% to 204% based on the volatility of comparable publicly traded entities; and exercise prices of $0.0182; and terms of eight to twelve months.	ASC Topic 820, “Fair Value Measurement”, requires that certain financial instruments be recognized at their fair values at our balance sheet dates. However, other financial instruments, such as debt obligations, are not required to be recognized at their fair values, but GAAP provides an option to elect fair value accounting for these instruments. GAAP requires the disclosure of the fair values of all financial instruments, regardless of whether they are recognized at their fair values or carrying amounts in our balance sheets. For financial instruments recognized at fair value, GAAP requires the disclosure of their fair values by type of instrument, along with other information, including changes in the fair values of certain financial instruments recognized in income or other comprehensive income. For financial instruments not recognized at fair value, the disclosure of their fair values is provided below under “Financial Instruments.” Nonfinancial assets, such as property, plant and equipment, and nonfinancial liabilities are recognized at their carrying amounts in the Company’s balance sheets. GAAP does not permit nonfinancial assets and liabilities to be remeasured at their fair values. However, GAAP requires the remeasurement of such assets and liabilities to their fair values upon the occurrence of certain events, such as the impairment of property, plant and equipment. In addition, if such an event occurs, GAAP requires the disclosure of the fair value of the asset or liability along with other information, including the gain or loss recognized in income in the period the remeasurement occurred. Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities; Level 2 - Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; or Level 3 - Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). The Company did not have any Level 1 or Level 2 assets and liabilities at December 31, 2022 or 2023. The Derivative liabilities are Level 3 fair value measurements. The following is a summary of activity of Level 3 liabilities for the year ended December 31, 2023: Balance - December 31, 2022 $ - Additions 445,616 Settlements (59,831 ) Change in fair value (192,759 ) Balance - December 31, 2023 $ 193,026 Beginning on June 27, 2023, the Company issued note payable agreements which contain conversion provisions meeting the definition of a derivative liability which therefore require bifurcation. Further, pursuant to the Company’s contract ordering policy, equity linked instruments subsequent to June 27, 2023, resulted in derivative liabilities. At December 31, 2023, the Company estimated the fair value of the conversion feature derivatives embedded in the notes payable and warrants based on assumptions used in the Cox-Ross-Rubinstein binomial pricing model using the following inputs: the price of the Company’s common stock of $0.0285; risk-free interest rates ranging from 4.79% to 5.03%; expected volatility of the Company’s common stock ranging from 110% to 204% based on the volatility of comparable publicly traded entities; and exercise prices of $0.0182; and terms of eight to twelve months.
Segment reporting	The Company operates in a single business segment. As a result, the Company’s operations are a single reportable segment, which is consistent with the Company’s internal management reporting.	The Company operates in a single business segment. As a result, the Company’s operations are a single reportable segment, which is consistent with the Company’s internal management reporting.
Subsequent Events		The Company has evaluated all subsequent events from December 31, 2023, through the date of filing of this report. and determined that there were no events or transactions required recognition or disclosure in the accompanying financial statements. (see Note 8).
Recent Accounting Pronouncements	The Company has considered the potential impact of recent accounting pronouncements and has not identified any that are expected to have a material impact on the financial statements.	The Company has considered the potential impact of recent accounting pronouncements and has not identified any that are expected to have a material impact on the financial statements.
Selling and Marketing	Selling and marketing costs are expensed as incurred and are reported under selling, general and administrative in the accompanying condensed statements of operations. Selling, general and administrative costs were $686,660 and $753,027 during the six months ended June 30, 2024 and 2023, respectively.

BASIS OF PRESENTATION AND SUM_3

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of derivative liabilities fair value	Balance - December 31, 2023 $ 193,026 Additions 87,627 Settlements 151,440 Change in fair value (369,573 ) Balance - June 30, 2024 $ 62,520	Balance - December 31, 2022 $ - Additions 445,616 Settlements (59,831 ) Change in fair value (192,759 ) Balance - December 31, 2023 $ 193,026

DEBT (Tables)

DEBT (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
DEBT
Schedule of maturities of debt	2024 $ 295,055 2025 1,220,550 Total $ 1,515,605	2024 $ 114,542 2025 950,550 Total $ 1,065,092

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2023
INCOME TAXES
Schedule of components of income tax expense	2023 2022 Federal tax statutory rate 21.0 % 21.0 % Permanent differences - % - % Valuation allowance (21.0 )% (21.0 )% Effective rate - % - %
Schedule of deferred tax assets and liabilities	2023 2022 Deferred tax assets: Net operating loss carryforwards $ 537,032 $ 265,673 Total deferred tax asset 537,032 265,673 Valuation allowance (537,032 ) (265,673 ) Net deferred tax assets $ - $ -

BASIS OF PRESENTATION AND SUM_4

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Beginning balance	$ 193,026	$ 0
Additions	87,627	445,616
Settlements	151,440	(59,831)
Change in fair value	(369,573)	(192,759)
Ending balance	$ 62,520	$ 193,026

BASIS OF PRESENTATION AND SUM_5

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Allowance for doubtful accounts balance	$ 0		$ 0	$ 0
Exercise prices	$ 0.0182		$ 0.0182
Common stock share prices		$ 0.0440	$ 0.0285
Selling and Marketing costs	$ 686,660	$ 753,027	$ 1,709,100	$ 541,219
Common stock, shares outstanding	75,545,390		58,582,469	37,428,394
Class A Preferred Stock [Member]
Potentially dilutive shares	2,265,400
Letter of Intent [Member]
Investments			$ 15,000
Membership Interest Purchase Agreement [Member]
Investments			$ 50,000
Minimum [Member]
Risk-free interest rate		5.45%	4.79%
Expected volatility		117%	110%
Exercise prices		$ 0.0215
Maximum [Member]
Risk-free interest rate			5.03%
Expected volatility			204%

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	1 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Preferred stock, issued		55,920,127
Preferred stock converted into common shares			13,810,125
Preferred stock, shares converted		2,071,713
Promissory note related party			$ 950,550
Note Payable to related party		$ 63,456	63,456	$ 63,456
Accrued interest			2,714
Chief Executive Officer [Member]
Note Payable to related party			$ 215,500	540,000
Related Party Transaction, Due Date		Mar. 15, 2025	Mar. 15, 2025
Asset Purchase Agreement [Member]
Note Payable to related party	$ 63,456
Related Party Transaction, Amounts of Transaction	$ 1,902
Interest rate	5%
Monthly installments	$ 1,902
Maturity term period	three-year
Accrued interest			$ 6,346	$ 3,173
Accrued interest payable		$ 7,928	$ 6,346
Class A Convertible Preferred Stock [Member]
Preferred stock converted into common shares			13,810,125
Preferred stock, shares converted			552,405
Series A Preferred Stock [Member] | Vice President [Member]
Preferred stock, issued		40,000	200,001
Preferred stock value		$ 60,000
Series B Preferred Stock [Member] | Vice President [Member]
Preferred stock, issued		90

DEBT (Details)

DEBT (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
DEBT
2024		$ 114,542
2025		950,550
Total		$ 1,065,092
2024	$ 295,055
2025	1,220,550
Total	$ 1,515,605

DEBT (Details Narrative)

DEBT (Details Narrative) - USD ($)	1 Months Ended		6 Months Ended			12 Months Ended
	Feb. 28, 2024	Jun. 30, 2021	Jun. 30, 2024	Dec. 19, 2023	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Additional debt discounts	$ 87,627			$ 249,000
Issuance debt conversion features value	$ 87,627			$ 445,616
Convertible promissory note issued						$ 204,488
Description of conversion price						conversion price equal to 65% of the lowest trading price for the common stock during the ten-day period prior to the conversion date
Unamortized debt discount			$ 58,385			$ 20,323
Promissory note related party						950,550
Debt discount						9,476
Amortized debt discount			47,204			3,653
Carrying value of unamortized debt discount			231,599			178,653
Accrued interest						$ 2,714
Term of convertible promissory note						1 year
Settlement of derivative liabilities						$ 59,831
Note Payable to related party			63,456			63,456	$ 63,456
Accrued interest payable			7,928			$ 6,346
Derivative liabilities			151,440
Accrued interest			37,476
Note Payable to Shareholder			1,220,550
Minimum [Member]
Interest rate						8%
Maximum [Member]
Interest rate						9%
Chief Executive Officer [Member]
Increase in note payable to shareholder			$ 270,000		$ 2,521
Note Payable to related party						$ 215,500	540,000
Related Party Transaction, Due Date			Mar. 15, 2025			Mar. 15, 2025
Asset Purchase Agreement [Member]
Interest rate		5%
Accrued interest						$ 6,346	$ 3,173
Note Payable to related party		$ 63,456
Related Party Transaction, Amounts of Transaction		1,902
Monthly installments		$ 1,902
Maturity term period		three-year

CAPITAL STOCK (Details Narrativ

CAPITAL STOCK (Details Narrative) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Common stock, shares issued	75,545,390		58,582,469	37,428,394
Common stock, shares outstanding	75,545,390		58,582,469	37,428,394
Common stock, par value	$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock par value	$ 0.0001		$ 0.0001	$ 0.0001
Class A preferred stock shares issued			56,282,599
Common stock, shares authorized	5,000,000,000		5,000,000,000	5,000,000,000
Common Stock, Voting Rights	The holders of common stock are entitled to one vote for each share held		The holders of common stock are entitled to one vote for each share held
Preferred Stock, Voting Rights	Each share of Class A preferred stock entitles the holder thereof to 50 votes on any matters requiring a shareholder vote of the Company		Each share of Class A preferred stock entitles the holder thereof to 50 votes on any matters requiring a shareholder vote of the Company
Common stock issued in payment, shares	900,000		6,518,950
Common stock issued in payment, value	$ 43,400		$ 178,544
Share conversions, common shares			13,810,125
Common shares sold			825,000	325,000
Purchase shares of Common stock			412,500	162,500
Share conversions, shares			552,405
Liquidation, amount per share			$ 1
Common stock price per share			$ 0.50	$ 0.50
Preferred stock, shares issued	55,920,127
Preferred stock, shares authorized	100,000,000
Common stock issued, shares	16,962,921
Common stock upon conversion of convertible notes	2,071,713
Common stock upon conversion of convertible notes amount	$ 40,937	$ 0
Common shares sold	3,929,408
Purchase price of Common stock	$ 125,006
Chief Executive Officer [Member]
Share conversions, shares of Class A Preferred Stock	40,000		200,001
Preferred Stock, Conversion Basis	Each share of our Class A preferred stock is convertible into common stock on a one-for-25 basis at the option of the holder.		shares was determined to be $110,002 based on an assumed conversion at a one-for-25 ratio
Undesignated Preferred Stock [Member]
Preferred stock, shares authorized			40,000,000	40,000,000
Preferred stock, shares outstanding			0	0
Undesignated Preferred Shares [Member]
Preferred stock, shares authorized	39,999,900		40,000,000	40,000,000
Preferred stock, shares outstanding	0		0	0
Preferred stock, shares issued	0		0	0
Class A Preferred Stock [Member]
Share conversions, common shares			13,810,125
Preferred stock, shares designated	60,000,000
Share conversions, shares of Class A Preferred Stock	402,472		552,405
Number of preferred stock shares held by CEO			31,092,596
Preferred stock, shares outstanding			56,282,599
Class A Preferred Stock [Member] | Chief Executive Officer [Member]
Number of preferred stock shares held by CEO	31,102,596
Preferred stock, shares outstanding	55,920,127
Class A Preferred Stock [Member] | Board Of Directors Chairman
Preferred stock, shares outstanding	90
Convertible Preferred Stock One [Member]
Preferred stock, shares authorized			60,000,000	60,000,000
Class B Preferred Stock [Member]
Super voting Preferred stock	100
Preferred stock, shares outstanding	90
Class A Preferred Stock One [Member]
Share conversions, shares of Class A Preferred Stock	402,472
Share conversions, common shares	10,061,800

INCOME TAXES (Details)

INCOME TAXES (Details)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
INCOME TAXES
Federal tax statutory rate	21%	21%
Permanent differences	(0.00%)	(0.00%)
Valuation allowance	(21.00%)	(21.00%)
Effective rate	0%	0%

INCOME TAXES (Details 1)

INCOME TAXES (Details 1) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Deferred tax assets:
Net operating loss carry forwards	$ 537,032	$ 265,673
Total deferred tax asset	537,032	265,673
Valuation allowance	(537,032)	(265,673)
Net deferred tax assets	$ 0	$ 0

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	1 Months Ended
	Feb. 28, 2024	Feb. 28, 2023	Feb. 22, 2023	May 31, 2021	Dec. 31, 2023
Employment Agreement [Member]
Annual salary		$ 85,000		$ 250,000
Employment Agreement [Member] | Chief Executive Officer [Member]
Annual salary	$ 250,000			$ 250,000
Employment Agreement [Member] | VP Agreement [Member]
Annual salary	$ 97,000	$ 85,000
Letter of Intent [Member]
Agreement for the acquisition, description			On February 22, 2023, the Company entered into a Letter of Intent for the acquisition of a Fifty-One Percent (51%) ownership interest in a natural therapeutic products company for total purchase consideration of $7,140,000 consisting of cash payments of $150,000 and $6,990,000 in Company common stock
Investments					$ 15,000
Membership Interest Purchase Agreement [Member]
Agreement for the acquisition, description		On February 28, 2023, the Company entered into a Membership Interest Purchase Agreement for the acquisition of Fifty-One Percent (51%) of the Membership Units of a hemp distribution company for total purchase consideration consisting of 230,559 shares of the Company’s common stock and a cash payment of $50,000
Investments					$ 50,000

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - GHS investments, LLC [Member] - Subsequent Event [Member]	1 Months Ended
	Jul. 22, 2024 USD ($) shares
Principal amount of the convertible promissory note	$ 70,150
Common stock shares issued during period | shares	5,337,924
Common stock shares issued during period for consideration	$ 131,405